POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
High Impact

Proposed Changes to Medicare Pharmacy Performance Standards

Original title: To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes.

Record date · December 17, 2024

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Would Do

This bill requires the federal government to create standardized performance measures for pharmacies participating in Medicare Part D plans. It also mandates that health plans provide pharmacies with clear, standardized information about fees and payments for every drug claim processed.

Why it matters

If passed, this bill would change how pharmacies are evaluated and paid under Medicare Part D, potentially impacting the financial transparency and operational requirements for retail, mail-order, and specialty pharmacies starting in 2025.

Background
  • Mr. Griffith is a U.S. Representative for Virginia's 9th congressional district. context
  • Mr. Carter of Georgia is a U.S. Representative for Georgia's 1st congressional district. context

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Network pharmacies

Pharmacies will be subject to standardized performance measures and will receive new, standardized payment and fee information for claims.

Directly affected

PDP sponsors

Prescription drug plan sponsors must adopt standardized performance measures and provide standardized claim information to pharmacies.

Directly affected

MA organizations

Medicare Advantage organizations offering MA-PD plans must adopt standardized performance measures and provide standardized claim information to pharmacies.

Directly affected

Pharmacy benefit managers

PBMs acting on behalf of plans will be subject to the new transparency and performance measure reporting requirements.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

How will this affect my pharmacy?
If you operate a pharmacy under Medicare Part D, this bill would require plans to use standardized performance measures to evaluate you and provide you with transparent, standardized data on all fees and payments for every claim.
When do these changes take effect?
The requirements for standardized performance measures and transparency for pharmacies are set to begin for plan years starting on or after January 1, 2025.
Who is responsible for checking if these measures are fair?
The Office of the Inspector General (OIG) is required to conduct a comprehensive study of how these performance measures are applied and report their findings to Congress.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently filed. The next step in the legislative lifecycle is Committee.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Standardization of Pharmacy Metrics

The bill represents a shift toward federal oversight of private pharmacy performance contracts, moving away from decentralized, plan-specific metrics.

Connected Entities

Mr. Carter of Georgia, Pharmacy Quality Alliance, Office of the Inspector General and 2 more
PersonMr. Carter of Georgia“Co-sponsored the bill in the House of Representatives.”Map →
OrganizationPharmacy Quality Alliance“A multi-stakeholder consensus organization that may endorse pharmacy performance”Map →
OrganizationOffice of the Inspector General“Will conduct a study of pharmacy performance measures.”Map →
PersonMr. Griffith“Introduced the bill in the House of Representatives.”Map →
OrganizationCenters for Medicare & Medicaid Services“Provides oversight and guidance regarding Medicare Part D performance measures.”Map →

Sources

Open source document

www.congress.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz25
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record